Gene: PDE12
Official Full Name: phosphodiesterase 12provided by HGNC
Gene Summary: Enables poly(A)-specific ribonuclease activity. Involved in several processes, including cellular response to interferon-alpha; innate immune response; and mRNA catabolic process. Located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37169 | PDE12 Knockout cell line (HeLa) | Human | PDE12 | 1:3~1:6 | Negative | Online Inquiry |
KO37170 | PDE12 Knockout cell line (HCT 116) | Human | PDE12 | 1:2~1:4 | Negative | Online Inquiry |
KO37171 | PDE12 Knockout cell line (HEK293) | Human | PDE12 | 1:3~1:6 | Negative | Online Inquiry |
KO37172 | PDE12 Knockout cell line (A549) | Human | PDE12 | 1:3~1:4 | Negative | Online Inquiry |
PDE12 Gene Knockout Cell Lines are invaluable research tools designed to investigate the biological roles of the PDE12 gene, which encodes a member of the phosphodiesterase family involved in regulating cellular signaling by hydrolyzing cyclic nucleotides (cAMP and cGMP). By creating precise gene knockouts using advanced CRISPR/Cas9 technology, these cell lines allow researchers to elucidate the functional consequences of PDE12 loss on cellular processes such as proliferation, differentiation, apoptosis, and signal transduction.
The primary function of PDE12 is to modulate cyclic nucleotide levels, thereby influencing various signaling pathways crucial for maintaining cellular homeostasis and responding to extracellular cues. This regulation impacts a range of metabolic and physiological responses, making PDE12 a key player in several biological contexts. By utilizing PDE12 knockout cell lines, scientists can gain insights into disease mechanisms associated with phosphodiesterase dysfunction, including cancer, cardiovascular diseases, and neurological disorders.
The scientific importance of these cell lines spans both basic and translational research. In clinical settings, the understanding of PDE12's role can inform therapeutic strategies aimed at targeting specific signal transduction pathways, paving the way for innovative drug development. Moreover, these knockout models can serve as valuable platforms for screening potential therapeutics, testing drug efficacy, and studying pathophysiological mechanisms.
One of the key advantages of using PDE12 Gene Knockout Cell Lines is their high specificity and reliability compared to existing alternatives, such as pharmacological inhibitors that may have off-target effects. The use of genetic knockout models enables a more accurate assessment of the gene's role in physiological and pathological processes, thus providing clearer insights and data reproducibility.
For researchers and clinicians, these knockout cell lines represent a vital resource for dissecting complex biological interactions and accelerating the discovery of novel therapeutic agents. With an established reputation for providing high-quality biological products and cutting-edge research tools, our company stands at the forefront of delivering precise solutions tailored to meet the evolving needs of the scientific community. By leveraging PDE12 Gene Knockout Cell Lines, researchers can unlock new dimensions in their studies and advance our understanding of critical biological mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.